XOMA (XOMA) News Today $20.74 -0.19 (-0.91%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period StockNews.com Upgrades XOMA (NASDAQ:XOMA) to "Hold"March 23 at 2:11 AM | americanbankingnews.comQ1 Earnings Estimate for XOMA Issued By HC WainwrightMarch 23 at 1:11 AM | americanbankingnews.comXOMA (NASDAQ:XOMA) Stock Rating Upgraded by StockNews.comStockNews.com upgraded XOMA from a "sell" rating to a "hold" rating in a research note on Friday.March 22 at 11:17 PM | marketbeat.comHC Wainwright Comments on XOMA's Q1 Earnings (NASDAQ:XOMA)XOMA Co. (NASDAQ:XOMA - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for XOMA in a report issued on Wednesday, March 19th. HC Wainwright analyst J. Pantginis forecasts that the biotechnology company will earn ($0.20) per shareMarch 22 at 6:33 AM | marketbeat.comLeerink Partnrs Has Positive Outlook of XOMA FY2025 EarningsMarch 22 at 2:49 AM | americanbankingnews.comLeerink Partnrs Issues Optimistic Forecast for XOMA EarningsXOMA Co. (NASDAQ:XOMA - Free Report) - Investment analysts at Leerink Partnrs boosted their FY2025 earnings estimates for XOMA in a research note issued on Tuesday, March 18th. Leerink Partnrs analyst D. Risinger now forecasts that the biotechnology company will post earnings per share of ($0.60)March 21, 2025 | marketbeat.comXOMA Preferred Shares Series A declares $0.539 dividendMarch 20, 2025 | seekingalpha.comXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendMarch 20, 2025 | seekingalpha.comXOMA Royalty Declares Quarterly Preferred Stock DividendsMarch 20, 2025 | gurufocus.comXOMA's (XOMA) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $104.00 price target on shares of XOMA in a report on Wednesday.March 20, 2025 | marketbeat.comXOMA Royalty Declares Quarterly Preferred Stock DividendsMarch 20, 2025 | globenewswire.comLeerink Partnrs Estimates XOMA's Q1 Earnings (NASDAQ:XOMA)XOMA Co. (NASDAQ:XOMA - Free Report) - Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for XOMA in a research report issued to clients and investors on Tuesday, March 18th. Leerink Partnrs analyst D. Risinger expects that the biotechnology company will poMarch 20, 2025 | marketbeat.comXOMA (NASDAQ:XOMA) Earns Buy Rating from HC WainwrightMarch 20, 2025 | americanbankingnews.comQ1 Earnings Forecast for XOMA Issued By Leerink PartnrsMarch 20, 2025 | americanbankingnews.comXOMA Royalty Full Year 2024 Earnings: EPS Misses ExpectationsMarch 19, 2025 | finance.yahoo.comXOMA Royalty Corp (XOMA) Reports Q4 EPS of -$0.30, Revenue of $8. ...March 19, 2025 | gurufocus.comXOMA (NASDAQ:XOMA) Releases Quarterly Earnings Results, Misses Expectations By $0.17 EPSXOMA (NASDAQ:XOMA - Get Free Report) issued its quarterly earnings data on Monday. The biotechnology company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.17). XOMA had a negative net margin of 151.34% and a negative return on equity of 24.95%.March 18, 2025 | marketbeat.comXOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business AchievementsMarch 17, 2025 | globenewswire.comXOMA (XOMA) to Release Earnings on FridayXOMA (NASDAQ:XOMA) will be releasing earnings before the market opens on Friday, March 14, Financial Modeling Prep reports.March 7, 2025 | marketbeat.comXOMA (NASDAQ:XOMA) Downgraded by StockNews.com to "Sell"StockNews.com downgraded shares of XOMA from a "hold" rating to a "sell" rating in a research note on Tuesday.February 26, 2025 | marketbeat.comLigand Leads $75 Million Royalty Financing in Castle Creek BiosciencesFebruary 25, 2025 | globenewswire.comXOMA Royalty to Present at Investor Conferences in MarchFebruary 24, 2025 | globenewswire.comAcuitas Investments LLC Has $1.60 Million Position in XOMA Co. (NASDAQ:XOMA)Acuitas Investments LLC lowered its stake in shares of XOMA Co. (NASDAQ:XOMA - Free Report) by 31.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 60,704 shares of the biotechnology company's stock after selling 27,354 sFebruary 18, 2025 | marketbeat.comXOMA (NASDAQ:XOMA) Upgraded by StockNews.com to Hold RatingStockNews.com upgraded shares of XOMA from a "sell" rating to a "hold" rating in a report on Tuesday.February 11, 2025 | marketbeat.comXOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | globenewswire.comXOMA (NASDAQ:XOMA) Downgraded to Sell Rating by StockNews.comStockNews.com cut XOMA from a "hold" rating to a "sell" rating in a report on Monday.February 3, 2025 | marketbeat.comXOMA (NASDAQ:XOMA) Price Target Lowered to $104.00 at HC WainwrightHC Wainwright lowered their price target on XOMA from $123.00 to $104.00 and set a "buy" rating on the stock in a report on Monday.February 3, 2025 | marketbeat.comInsider Selling: XOMA Co. (NASDAQ:XOMA) Major Shareholder Sells 500,742 Shares of StockXOMA Co. (NASDAQ:XOMA - Get Free Report) major shareholder Bvf Partners L. P/Il sold 500,742 shares of the company's stock in a transaction on Friday, January 24th. The shares were sold at an average price of $26.10, for a total value of $13,069,366.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.January 28, 2025 | marketbeat.comOptimistic Long-term Revenue Potential for Xoma Driven by Vabysmo Royalties and Market PerformanceJanuary 15, 2025 | markets.businessinsider.comXOMA Royalty Corporation: High-Risk Royalty Aggregator Best AvoidedJanuary 15, 2025 | seekingalpha.comBuy Rating for Xoma Driven by Promising Drug Advancements and Strong Partnership PipelineJanuary 8, 2025 | markets.businessinsider.comStockNews.com Downgrades XOMA (NASDAQ:XOMA) to SellStockNews.com lowered XOMA from a "hold" rating to a "sell" rating in a research note on Wednesday.January 8, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for XOMA (NASDAQ:XOMA)HC Wainwright reiterated a "buy" rating and set a $123.00 target price on shares of XOMA in a research report on Tuesday.January 7, 2025 | marketbeat.comXOMA Corp - 8.375% DP PFD B goes ex dividend tomorrowJanuary 2, 2025 | msn.comXOMA Co. (NASDAQ:XOMA) Sees Significant Growth in Short InterestXOMA Co. (NASDAQ:XOMA - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 139,000 shares, a growth of 23.4% from the November 30th total of 112,600 shares. Based on an average daily volume of 29,100 shares, the short-interest ratio is presently 4.8 days.December 29, 2024 | marketbeat.comXOMA (NASDAQ:XOMA) Lowered to "Sell" Rating by StockNews.comStockNews.com downgraded XOMA from a "hold" rating to a "sell" rating in a research note on Friday.December 27, 2024 | marketbeat.comXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendDecember 19, 2024 | seekingalpha.comXOMA Preferred Shares Series A declares $0.5391 dividendDecember 19, 2024 | seekingalpha.comXOMA Royalty Declares Quarterly Preferred Stock DividendsDecember 19, 2024 | globenewswire.comXoma’s Strategic Partnerships and Promising Pipeline Drive Buy RatingDecember 14, 2024 | markets.businessinsider.comXOMA's (XOMA) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $123.00 target price on shares of XOMA in a report on Friday.December 13, 2024 | marketbeat.comXOMA Co. (NASDAQ:XOMA) Shares Sold by Fmr LLCFmr LLC decreased its position in shares of XOMA Co. (NASDAQ:XOMA - Free Report) by 4.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,102,401 shares of the biotechnology company's stocDecember 10, 2024 | marketbeat.comA Glimpse Into The Expert Outlook On XOMA Royalty Through 4 AnalystsDecember 3, 2024 | benzinga.comStrategic Acquisitions and Growth Potential Bolster Xoma’s Buy RatingDecember 3, 2024 | markets.businessinsider.comXOMA Royalty Owns Economic Interest In Seralutinib With Pulmokine Purchase; Stock UpDecember 2, 2024 | markets.businessinsider.comXOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its PortfolioDecember 2, 2024 | finance.yahoo.comXOMA (XOMA) Stock Surges Amid Positive Market MovementNovember 26, 2024 | gurufocus.comTop Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 EarningsNovember 18, 2024 | benzinga.comXOMA Co. (NASDAQ:XOMA) Sees Significant Decrease in Short InterestXOMA Co. (NASDAQ:XOMA - Get Free Report) was the recipient of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 173,300 shares, a drop of 23.5% from the October 15th total of 226,400 shares. Based on an average trading volume of 22,100 shares, the days-to-cover ratio is presently 7.8 days.November 15, 2024 | marketbeat.comOwen Hughes Sells 21,881 Shares of XOMA Co. (NASDAQ:XOMA) StockNovember 14, 2024 | insidertrades.com Remove Ads Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address XOMA Media Mentions By Week XOMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMA News Sentiment▼0.430.63▲Average Medical News Sentiment XOMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMA Articles This Week▼272▲XOMA Articles Average Week Remove Ads Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Myriad Genetics News Rigel Pharmaceuticals News Emergent BioSolutions News Verastem News Vanda Pharmaceuticals News Codexis News Ironwood Pharmaceuticals News Sangamo Therapeutics News Achieve Life Sciences News Regulus Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMA) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
